Mechanism of enhanced hematopoietic response by soluble β-glucan SCG in cyclophosphamide-treated mice

Microbiology and Immunology

Volumn 50, Issue 9, 2006, Pages 687-700

  Harada, Toshie ^a   Kawaminami, Hiromi ^a   Miura, Noriko N ^a   Adachi, Yoshiyuki ^a   Nakajima, Mitsuhiro ^b   Yadomae, Toshiro ^a   Ohno, Naohito ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b Minahealth Co   (Japan)

Author keywords

Cyclophosphamide; Dectin 1; GM CSF; Glucan

Indexed keywords

BETA GLUCAN; CYCLOPHOSPHAMIDE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12P70; INTERLEUKIN 6; SPARASSIS CRISPA BETA GLUCAN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APHYLLOPHORALES; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; HEMATOPOIESIS; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; SPARASSIS CRISPA; SPLEEN CELL;

SPARASSIS CRISPA;

EID: 33748925365     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03841.x     Document Type: Article

References (50)

1. Adachi, Y., Ishii, T., Ikeda, Y., Hoshino, A., Tamura, H., Aketagawa, J., Tanaka, S., and Ohno, N. 2004. Characterization of beta-glucan recognition site on C-type lectin, dectin 1. Infect. Immun. 72: 4159-4171.
2. Adachi, Y., Okazaki, M., Ohno, N., and Yadomae, T. 1994. Enhancement of cytokine production by macrophages stimulated with (1→3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol. Pharm. Bull. 17: 1554-1560.
3. Brown, G.D., Herre, J., Williams, D.L., Willment, J.A., Marshall, A.S., and Gordon, S. 2003. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 197: 1119-1124.
4. Chamoto, K., Kosaka, A., Tsuji, T., Matsuzaki, J., Sato, T., Takeshima, T., Iwakabe, K., Togashi, Y., Koda, T., and Nishimura, T. 2003. Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy. Cancer Sci. 94: 924-928.
5. Chen, B.D., Clark, C.R., and Chou, T.H. 1988. Granulocyte/macrophage colony-stimulating factor stimulates monocyte and tissue macrophage proliferation and enhances their responsiveness to macrophage colony-stimulating factor. Blood 71: 997-1002.
6. Czop, J.K., and Austen, K.F. 1985. Properties of glycans that activate the human alternate complement pathway and interact with human monocytes beta glucan receptors. J. Immunol. 135: 3388-3393.
7. Etcalf, D. 1989. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339: 27-30.
8. Fosdick, W.M., Parsons, J.L., and Hill, D.F. 1968. Long-term cyclophosphamide therapy in rheumatoid arthritis. Arthritis Rheum. 11: 151-161.
9. Fujimoto, S., Orita, K., Kimura, T., Kondo, T., Taguchi, T., Yoshida, K., Ogawa, N., and Furue, H. 1983. [Clinical evaluation of SPG (schizophyllan) as a therapeutic adjuvant after surgery of gastric cancer - controlled study by an envelope method]. Gan To Kagaku Ryoho 10: 1135-1145.
10. Harada, T., Masuda, S., Arii, M., Adachi, Y., Nakajima, M., Yadomae, T., and Ohno, N. 2005. Soy isoflavone aglycone modulates a hematopoietic response in combination with soluble beta-glucan: SCG. Biol. Pharm. Bull. 28: 2342-2345.
11. Harada, T., Miura, N.N., Adachi, Y., Nakajima, M., Yadomae, T., and Ohno, N. 2002. Effect of SCG, 1,3-β-D-glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice. Biol. Pharm. Bull. 25: 931-939.
12. Harada, T., Miura, N.N., Adachi, Y., Nakajima, M., Yadomae, T., and Ohno, N. 2002. IFN-gamma induction by SCG, 1,3-beta-D-glucan from Sparassis crispa, in DBA/2 mice in vitro. J. Interferon Cytokine Res. 22: 1227-1239.
13. Harada, T., Miura, N.N., Adachi, Y., Nakajima, M., Yadomae, T., and Ohno, N. 2003. Antibody to soluble 1,3/1,6-beta-D-glucan, SCG in sera of naive DBA/2 mice. Biol. Pharm. Bull. 26: 1225-1228.
14. Harada, T., Miura, N.N., Adachi, Y., Nakajima, M., Yadomae, T., and Ohno, N. 2004. Granulocyte-macrophage colony-stimulating factor (GM-CSF) regulates cytokine induction by 1,3-beta-D-glucan SCG in DBA/2 mice in vitro. J. Interferon Cytokine Res. 24: 478-489.
15. Harada, T., Miura, N.N., Adachi, Y., Nakajima, M., Yadomae, T., and Ohno, N. 2006. Cell to cell contact through ICAM-1 - LFA-1 and TNF-α synergistically contribute to GM-CSF and subsequent cytokine synthesis in DBA/2 mice induced by 1,3-beta-D-glucan SCG. J. Interferon Cytokine Res. 26: 235-247.
16. Hashimoto, T., Ohno, N., Adachi, Y., and Yadomae, T. 1997. Nitric oxide synthesis in murine peritoneal macrophages by fungal beta-glucans. Biol. Pharm. Bull. 20: 1006-1009.
17. Hida, S., Miura, N.N., Adachi, Y., and Ohno, N. 2005. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice. J. Autoimmun. 25: 93-101.
18. Hill, D.L. 1975. A review of cyclophosphamide, C.C. Thomas Publisher, Springfield, Ill.
19. Hiramine, C., Nakagawa, T., Miyauchi, A., and Hojo, K. 1996. Thymic nurse cells as the site of thymocyte apoptosis and apoptotic cell clearance in the thymus of cyclophosphamide-treated mice. Lab. Invest. 75: 185-201.
20. Hong, F., Hansen, R.D., Yan, J., Allendorf, D.J., Baran, J.T., Ostroff, G.R., and Ross, G.D. 2003. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res. 63: 9023-9031.
21. Hong, F., Yan, J., Baran, J.T., Allendorf, D.J., Hansen, R.D., Ostroff, G.R., Xing, P.X., Cheung, N.K., and Ross, G.D. 2004. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol. 173: 797-806.
22. Ikeda, Y., Adachi, Y., Ishibashi, K., Miura, N., and Ohno, N. 2005. Activation of toll-like receptor-mediated NF-kappa beta by zymosan-derived water-soluble fraction: possible contribution of endotoxin-like substances. Immunopharmacol. Immunotoxicol. 27: 285-298.
23. Kozuka, T., Ikeda, K., Teshima, T., Kojima, K., Matsuo, K., Bessho, A., Sunami, K., Hiramatsu, Y., Maeda, Y., Noguchi, T., Yamamoto, K., Fujii, N., Imai, T., Takenaka, K., Shinagawa, K., Ishimaru, F., Niiya, K., Koide, N., Tanimoto, M., and Harada, M. 2002. Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G-CSF plus chemotherapy-induced mobilization. Transfusion 42: 1514-1522.
24. Lotem, J., and Sachs, L. 1992. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 80: 1750-1757.
25. Lutsiak, M.E., Semnani, R.T., De Pascalis, R., Kashmiri, S.V., Schlom, J., and Sabzevari, H. 2005. Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 105: 2862-2868.
26. Mimura, H., Ohno, N., Suzuki, I., and Yadomae, T. 1985. Purification, antitumor activity, and structural characterization of beta-1,3-glucan from Peziza vesiculosa. Chem. Pharm. Bull. (Tokyo) 33: 5096-5099.
27. Mitsuoka, A., Baba, M., and Morikawa, S. 1976. Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice. Nature 262: 77-78.
28. Nameda, S., Harada, T., Miura, N.N., Adachi, Y., Yadomae, T., Nakajima, M., and Ohno, N. 2003. Enhanced cytokine synthesis of leukocytes by a β-glucan preparation, SCG, extracted from a medicinal mushroom, Sparassis crispa. Immunopharmacol. Immunotoxicol. 25: 321-335.
29. Nishimura, T., Togashi, Y., Goto, M., Yagi, H., Uchiyama, Y., and Hashimoto, Y. 1986. Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2. Cancer Immunol. Immunother. 21: 12-18.
30. Ohno, N., Harada, T., Masuzawa, S., Miura, N.N., Adachi, Y., Nakajima, M., and Yadomae, T. 2002. Antitumor activity and hematopoietic response of β-glucan extracted from an edible and medicinal mushroom Sparassis crispa wulf.:Fr (Aphyllophoromycetideae). Int. J. Medicinal Mushrooms 4: 13-26.
31. Ohno, N., Kurachi, K., and Yadomae, T. 1987. Antitumor activity of a highly branched (1→3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395. J. Pharmacobiodyn. 10: 478-486.
32. Ohno, N., Miura, T., Miura, N.N., Chiba, N., Uchiyama, M., Adachi, Y., and Yadomae, T. 1999. Inflammatory and immunopharmacological activity of meta-periodate oxidized zymosan. Zentralbl. Bakteriol. 289: 63-77.
33. Ohno, N., Miura, T., Miura, N.N., Sugawara, N., Tokunaka, K., Kirigaya, N., and Yadomae, T. 1998. Immunomodulation by hot water and ethanol extracts of Ganoderma lucidum. Pharm. Pharmacol. Lett. 8: 174-177.
34. Ohno, N., Miura, N.N., Nakajima, M., and Yadomae, T. 2000. Antitumor 1,3-beta-glucan from cultured fruit body of Sparassis crispa. Biol. Pharm. Bull. 23: 866-872.
35. Ohno, N., Nameda, S., Harada, T., Miura, N.N., Adachi, Y., Nakajima, M., Yoshida, K., Yoshida, H., and Yadomae, T. 2003. Immunomodulating activity of a β-glucan preparation, SCG, extracted from a culinary-medicinal mushroom, Sparassis crispa Wulf.:Fr. (Aphyllophoromycetideae), and application to cancer patients. Int. J. Medicinal Mushrooms 5: 373-381.
36. Ohno, N., Saito, K., Nemoto, J., Kaneko, S., Adachi, Y., Nishijima, M., Miyazaki, T., and Yadomae, T. 1993. Immunopharmacological characterization of a highly branched fungal (1→3)-beta-D-glucan, OL-2, isolated from Omphalia lapidescens. Biol. Pharm. Bull. 16: 414-419.
37. Rogers, N.C., Slack, E.C., Edwards, A.D., Nolte, M.A., Schulz, O., Schweighoffer, E., Williams, D.L., Gordon, S., Tybulewicz, V.L., Brown, G.D., Reis, E., Sousa, C. 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22: 507-517.
38. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
39. Suzuki, T., Tsuzuki, A., Ohno, N., Ohshima, Y., and Yadomae, T. 2000. Enhancement of IL-8 production from human monocytic and granulocytic cell lines, THP-1 and HL-60, stimulated with Malassezia furfur. FEMS Immunol. Med. Microbiol. 28: 157-162.
40. Taguchi, T., Furue, H., Kimura, T., Kondo, T., Hattori, T., and Ogawa, N. 1983. Clinical efficacy of lentinan on neoplastic diseases. Adv. Exp. Med. Biol. 166: 181-187.
41. Taylor, P.R., Brown, G.D., Reid, D.M., Willment, J.A., Martinez-Pomares, L., Gordon, S., and Wong, S.Y. 2002. The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol. 169: 3876-3882.
42. Thornton, B.P., Vetvicka, V., Pitman, M., Goldman, R.C., and Ross, G.D. 1996. Beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156: 1235-1246.
43. Tokunaka, K., Ohno, N., Adachi, Y., Tanaka, S., Tamura, H., and Yadomae, T. 2000. Immunopharmacological and immunotoxicological activities of a water-soluble (1→3)-beta-D-glucan, CSBG from Candida spp. Int. J. Immunopharmacol. 22: 383-394.
44. Tsung, K., Meko, J.B., Tsung, Y.L., Peplinski, G.R., and Norton, J.A. 1998. Immune response against large tumors eradicated by treatment with cyclophosphamide and IL-12. J. Immunol. 160: 1369-1377.
45. Van Snick, J. 1990. Interleukin-6: an overview. Annu. Rev. Immunol. 8: 253-278.
46. Vierboom, M.P., Bos, G.M., Ooms, M., Offringa, R., and Melief, C.J. 2000. Cyclophosphamide enhances anti-tumor effect of wild-type p53-specific CTL. Int. J. Cancer 87: 253-260.
47. Willment, J.A., Lin, H.H., Reid, D.M., Taylor, P.R., Williams, D.L., Wong, S.Y., Gordon, S., and Brown, G.D. 2003. Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. Immunology 171: 4569-4573.
48. Yadomae, T. 2000. [Structure and biological activities of fungal beta-1,3-glucans]. Yakugaku Zasshi 120: 413-431.
49. Yadomae, T., and Ohno, N. 1996. Structure-activity relationship of immunomodulating (1→3)-beta-D-glucans. Recent Res. Devel. in Chem. & Pharm. Sciences 1: 23-33.
50. Yoshitomi, H., Sakaguchi, N., Kobayashi, K., Brown, G.D., Tagami, T., Sakihama, T., Hirota, K., Tanaka, S., Nomura, T., Miki, I., Gordon, S., Akira, S., Nakamura, T., and Sakaguchi, S. 2005. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 201: 949-960.